PubRank

H Kalbacher

Author PubWeight™ 74.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 1999 6.44
2 Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 2001 5.06
3 Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol 2001 2.29
4 Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol 2000 1.92
5 Trefoil factor family-peptides promote migration of human bronchial epithelial cells: synergistic effect with epidermal growth factor. Am J Respir Cell Mol Biol 2001 1.65
6 Two new proteases in the MHC class I processing pathway. Nat Immunol 2000 1.63
7 Limit of T cell tolerance to self proteins by peptide presentation. Science 1990 1.49
8 Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells. Leukemia 2009 1.40
9 Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3. Cancer Res 1997 1.38
10 Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. Eur J Cell Biol 2000 1.34
11 Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol 1994 1.32
12 Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob Agents Chemother 2006 1.18
13 Two classes of outer hair cells along the tonotopic axis of the cochlea. Neuroscience 2006 1.16
14 Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells. Cancer Immunol Immunother 1998 1.15
15 A rapid method to separate endosomes from lysosomal contents using differential centrifugation and hypotonic lysis of lysosomes. J Immunol Methods 1999 1.13
16 A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus. J Virol 1992 1.11
17 Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J Exp Med 1992 1.08
18 Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur J Immunol 2001 1.07
19 Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin-1, -2 and -5 expression by protein kinase C. Neuroreport 2000 1.05
20 Control of K+ channel gating by protein phosphorylation: structural switches of the inactivation gate. Nat Struct Biol 1999 1.05
21 Solution conformation of thymosin beta 4: a nuclear magnetic resonance and simulated annealing study. Biochemistry 1990 1.04
22 Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol 2004 1.04
23 Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells. Brain Res 2000 1.03
24 Thymosin beta 4Xen: a new thymosin beta 4-like peptide in oocytes of Xenopus laevis. Arch Biochem Biophys 1988 0.98
25 Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 1997 0.97
26 Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming. J Immunol 1993 0.93
27 Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets. Biochemistry 1991 0.92
28 T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells. J Neuroimmunol 1997 0.92
29 Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides. Eur J Immunol 1996 0.90
30 Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients. Mult Scler 2000 0.89
31 Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method. Cancer Res 1998 0.87
32 New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library. Eur J Biochem 1996 0.86
33 NMR structure and functional characteristics of the hydrophilic N terminus of the potassium channel beta-subunit Kvbeta1.1. J Biol Chem 1999 0.86
34 Differential behavioral effects of TFF peptides: injections of synthetic TFF3 into the rat amygdala. Pharmacol Biochem Behav 1999 0.85
35 Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. Lab Invest 1998 0.85
36 Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice. Int Immunol 1998 0.85
37 Defensins are dominant HLA-DR-associated self-peptides from CD34(-) peripheral blood mononuclear cells of different tumor patients (plasmacytoma, chronic myeloid leukemia). Blood 2000 0.83
38 BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors. Blood 1996 0.82
39 The role of endogenous peptides in the direct pathway of alloreactivity to human MHC class II molecules expressed on CHO cells. Immunol Rev 1996 0.81
40 Biotinylated fluorescent peptide substrates for the sensitive and specific determination of cathepsin D activity. J Pept Sci 2005 0.81
41 Characterization of peptides bound to extracellular and intracellular HLA-DR1 molecules. Hum Immunol 1993 0.81
42 T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes. Exp Clin Endocrinol Diabetes 1999 0.80
43 Analysis of T-cell reactive regions and HLA-DR4 binding motifs on the latex allergen Hev b 1 (rubber elongation factor). Clin Exp Allergy 1998 0.80
44 Peptide-specific antibodies indicate species heterogeneity of a 42 kDa high-affinity inositol 1,3,4,5-tetrakisphosphate receptor protein from brain. Biochem Biophys Res Commun 1995 0.79
45 Characterization of a high-affinity Ins-P4 (inositol 1,3,4,5-tetrakisphosphate) receptor from brain by an anti-peptide antiserum. FEBS Lett 1995 0.79
46 Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha. Leuk Lymphoma 1995 0.79
47 Resistance to dermcidin-derived peptides is independent of bacterial protease activity. Int J Antimicrob Agents 2009 0.79
48 In vitro processing of insulin for recognition by murine T cells results in the generation of A chains with free CysSH. J Immunol 1992 0.79
49 Presence of argininosuccinate synthetase in glial cells as revealed by peptide-specific antisera. Biol Chem 1997 0.79
50 Evidence for cobinding of self- and allopeptides to human class II major histocompatibility antigen DR1 by energy transfer. Proc Natl Acad Sci U S A 1993 0.78
51 The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes. Scand J Immunol 1992 0.78
52 Identification of HLA-DR and -DQ alleles conferring susceptibility to pollen allergy and pollen associated food allergy. Clin Exp Allergy 1998 0.78
53 Requirements for stimulation or anergy induction in alloreactive human T cell clones. Cell Immunol 1994 0.78
54 Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein. Int Immunol 1996 0.78
55 Presentation of insulin and insulin A chain peptides to mouse T cells: involvement of cysteine residues. Mol Immunol 1991 0.78
56 Modulation of p145c-kit function in cells of patients with acute myeloblastic leukemia. Cancer Res 1993 0.78
57 Cellular uptake of cationic gadolinium-DOTA peptide conjugates with and without N-terminal myristoylation. Amino Acids 2008 0.78
58 Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells. Tissue Antigens 1998 0.78
59 Immunohistochemical localization of thymosin beta 9 in bovine tissues. Histochemistry 1990 0.77
60 Acetylcholine receptor-specific T cells are present in the normal immune repertoire. A study with recombinant polypeptides of the human acetylcholine receptor alpha-subunit. Ann N Y Acad Sci 1993 0.77
61 Bioactive motifs of agouti signal protein. Exp Cell Res 2000 0.77
62 Analysis of T helper cell response to glycoprotein H (gpUL75) of human cytomegalovirus: evidence for strain-specific T cell determinants. J Infect Dis 1996 0.77
63 A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4Dw4-associated self-peptide. Hum Immunol 1994 0.77
64 Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA-DRB1*0405 by a FXXL motif. Immunology 1999 0.77
65 Indirect coating of RGD peptides using a poly-L-lysine spacer enhances jaw periosteal cell adhesion, proliferation, and differentiation into osteogenic tissue. J Biomed Mater Res A 2012 0.77
66 Molecular parameters in melittin immunogenicity. J Pept Sci 1997 0.76
67 Tumor-specific antigens revisited: presentation to the immune system of fusion peptides resulting solely from tumor-specific chromosomal translocations. Oncol Res 1992 0.76
68 The antirheumatic drug disodium aurothiomalate inhibits CD4+ T cell recognition of peptides containing two or more cysteine residues. J Immunol 1995 0.75
69 Immunoassays of peptide hormones and their chemical aspects. Biopolymers 1983 0.75
70 [Hypothalamus regulatory hormones]. Med Welt 1978 0.75
71 Evidence for distinct mechanisms in the shaping of the CD4 T cell repertoire in histologically distinct myasthenia gravis-associated thymomas. Dev Immunol 2001 0.75
72 [Immunodetermination of peptide factors. I. Synthesis of N-alpha-maleoyl-peptide derivatives]. Biol Chem Hoppe Seyler 1985 0.75
73 Novel cell nucleus directed fluorescent tetraazacyclododecane-tetra-acetic acid compounds. Med Chem 2009 0.75
74 MicroELISA method for the determination of thymosin beta 9 discriminating between thymosin beta 9 and the structurally closely related thymosin beta 4. J Immunol Methods 1989 0.75
75 [Synthesis and spectroscopic investigation of Namide-ethylthyroliberin (author's transl)]. Hoppe Seylers Z Physiol Chem 1975 0.75
76 Total synthesis of methionine-enkephalin. Angew Chem Int Ed Engl 1976 0.75
77 Role of three quantitatively dominant endogenous peptides from HLA-DRB1*0401 molecules in class II specific alloreactivity. Transpl Immunol 1994 0.75
78 Palmitoyl derivatives of GpMBP epitopes: T-cell response and peptidases susceptibility. J Med Chem 2001 0.75
79 The epitope recognized by a monoclonal antibody in the myelin-associated protein CNP. Biochem Biophys Res Commun 1997 0.75